 | • レポートコード：GIR201112091 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ハンチントン病タンパク質の世界市場を調査対象にし、ハンチントン病タンパク質の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（NI-302、NLF-HD、P-301905、IONIS-HTTRx、その他）、用途別分析（アルツハイマー病、ケネディ病、脊髄小脳失調症、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：AFFiRiS AG、Voyager Therapeutics, Inc.、nLife Therapeutics, S.L.、Ionis Pharmaceuticals, Inc.、UniQure N.V.、Neurimmune Holding AG、WAVE Life Sciences Ltd.、Sangamo BioSciences, Inc.、reMYND NV、Vybion, Inc. ・メーカー別販売量、売上、市場シェア ・ハンチントン病タンパク質の地域別市場分析 ・ハンチントン病タンパク質の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ハンチントン病タンパク質のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ハンチントン病タンパク質のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ハンチントン病タンパク質の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ハンチントン病タンパク質の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ハンチントン病タンパク質の種類別市場規模2015-2020：NI-302、NLF-HD、P-301905、IONIS-HTTRx、その他 ・ハンチントン病タンパク質の用途別市場規模2015-2020：アルツハイマー病、ケネディ病、脊髄小脳失調症、その他 ・ハンチントン病タンパク質の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Huntington Disease Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Huntington Disease Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Huntington Disease Protein market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Huntington Disease Protein market has been segmented into
NI-302
NLF-HD
P-301905
IONIS-HTTRx
Others
By Application, Huntington Disease Protein has been segmented into:
Alzheimer’s Disease
Kennedy’s Disease
Spinocerebellar Ataxia
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Huntington Disease Protein market presented in the report. This section sheds light on the sales growth of different regional and country-level Huntington Disease Protein markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Huntington Disease Protein market.
The report offers in-depth assessment of the growth and other aspects of the Huntington Disease Protein market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Huntington Disease Protein Market Share Analysis
Huntington Disease Protein competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Huntington Disease Protein sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Huntington Disease Protein sales, revenue and market share for each player covered in this report.
The major players covered in Huntington Disease Protein are:
AFFiRiS AG
Voyager Therapeutics, Inc.
nLife Therapeutics, S.L.
Ionis Pharmaceuticals, Inc.
UniQure N.V.
Neurimmune Holding AG
WAVE Life Sciences Ltd.
Sangamo BioSciences, Inc.
reMYND NV
Vybion, Inc.
Among other players domestic and global, Huntington Disease Protein market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Huntington Disease Protein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Huntington Disease Protein, with price, sales, revenue and global market share of Huntington Disease Protein in 2018 and 2019.
Chapter 3, the Huntington Disease Protein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Huntington Disease Protein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Huntington Disease Protein market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Huntington Disease Protein sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Huntington Disease Protein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Huntington Disease Protein Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 NI-302
1.2.3 NLF-HD
1.2.4 P-301905
1.2.5 IONIS-HTTRx
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Huntington Disease Protein Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Alzheimer’s Disease
1.3.3 Kennedy’s Disease
1.3.4 Spinocerebellar Ataxia
1.3.5 Others
1.4 Overview of Global Huntington Disease Protein Market
1.4.1 Global Huntington Disease Protein Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AFFiRiS AG
2.1.1 AFFiRiS AG Details
2.1.2 AFFiRiS AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AFFiRiS AG SWOT Analysis
2.1.4 AFFiRiS AG Product and Services
2.1.5 AFFiRiS AG Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Voyager Therapeutics, Inc.
2.2.1 Voyager Therapeutics, Inc. Details
2.2.2 Voyager Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Voyager Therapeutics, Inc. SWOT Analysis
2.2.4 Voyager Therapeutics, Inc. Product and Services
2.2.5 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 nLife Therapeutics, S.L.
2.3.1 nLife Therapeutics, S.L. Details
2.3.2 nLife Therapeutics, S.L. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 nLife Therapeutics, S.L. SWOT Analysis
2.3.4 nLife Therapeutics, S.L. Product and Services
2.3.5 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ionis Pharmaceuticals, Inc.
2.4.1 Ionis Pharmaceuticals, Inc. Details
2.4.2 Ionis Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ionis Pharmaceuticals, Inc. SWOT Analysis
2.4.4 Ionis Pharmaceuticals, Inc. Product and Services
2.4.5 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 UniQure N.V.
2.5.1 UniQure N.V. Details
2.5.2 UniQure N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 UniQure N.V. SWOT Analysis
2.5.4 UniQure N.V. Product and Services
2.5.5 UniQure N.V. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Neurimmune Holding AG
2.6.1 Neurimmune Holding AG Details
2.6.2 Neurimmune Holding AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Neurimmune Holding AG SWOT Analysis
2.6.4 Neurimmune Holding AG Product and Services
2.6.5 Neurimmune Holding AG Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 WAVE Life Sciences Ltd.
2.7.1 WAVE Life Sciences Ltd. Details
2.7.2 WAVE Life Sciences Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 WAVE Life Sciences Ltd. SWOT Analysis
2.7.4 WAVE Life Sciences Ltd. Product and Services
2.7.5 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sangamo BioSciences, Inc.
2.8.1 Sangamo BioSciences, Inc. Details
2.8.2 Sangamo BioSciences, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sangamo BioSciences, Inc. SWOT Analysis
2.8.4 Sangamo BioSciences, Inc. Product and Services
2.8.5 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 reMYND NV
2.9.1 reMYND NV Details
2.9.2 reMYND NV Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 reMYND NV SWOT Analysis
2.9.4 reMYND NV Product and Services
2.9.5 reMYND NV Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Vybion, Inc.
2.10.1 Vybion, Inc. Details
2.10.2 Vybion, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Vybion, Inc. SWOT Analysis
2.10.4 Vybion, Inc. Product and Services
2.10.5 Vybion, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Huntington Disease Protein Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Huntington Disease Protein Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Huntington Disease Protein Manufacturer Market Share in 2019
3.3.2 Top 6 Huntington Disease Protein Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Huntington Disease Protein Sales, Revenue and Market Share by Regions
4.1.1 Global Huntington Disease Protein Sales and Market Share by Regions (2015-2020)
4.1.2 Global Huntington Disease Protein Revenue and Market Share by Regions (2015-2020)
4.2 North America Huntington Disease Protein Sales and Growth Rate (2015-2020)
4.3 Europe Huntington Disease Protein Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Huntington Disease Protein Sales and Growth Rate (2015-2020)
4.5 South America Huntington Disease Protein Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Huntington Disease Protein Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Huntington Disease Protein Sales, Revenue and Market Share by Country
5.1.1 North America Huntington Disease Protein Sales and Market Share by Country (2015-2020)
5.1.2 North America Huntington Disease Protein Revenue and Market Share by Country (2015-2020)
5.2 United States Huntington Disease Protein Sales and Growth Rate (2015-2020)
5.3 Canada Huntington Disease Protein Sales and Growth Rate (2015-2020)
5.4 Mexico Huntington Disease Protein Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Huntington Disease Protein Sales, Revenue and Market Share by Country
6.1.1 Europe Huntington Disease Protein Sales and Market Share by Country (2015-2020)
6.1.2 Europe Huntington Disease Protein Revenue and Market Share by Country (2015-2020)
6.2 Germany Huntington Disease Protein Sales and Growth Rate (2015-2020)
6.3 UK Huntington Disease Protein Sales and Growth Rate (2015-2020)
6.4 France Huntington Disease Protein Sales and Growth Rate (2015-2020)
6.5 Russia Huntington Disease Protein Sales and Growth Rate (2015-2020)
6.6 Italy Huntington Disease Protein Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Huntington Disease Protein Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Huntington Disease Protein Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Huntington Disease Protein Revenue and Market Share by Regions (2015-2020)
7.2 China Huntington Disease Protein Sales and Growth Rate (2015-2020)
7.3 Japan Huntington Disease Protein Sales and Growth Rate (2015-2020)
7.4 Korea Huntington Disease Protein Sales and Growth Rate (2015-2020)
7.5 India Huntington Disease Protein Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Huntington Disease Protein Sales and Growth Rate (2015-2020)
7.7 Australia Huntington Disease Protein Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Huntington Disease Protein Sales, Revenue and Market Share by Country
8.1.1 South America Huntington Disease Protein Sales and Market Share by Country (2015-2020)
8.1.2 South America Huntington Disease Protein Revenue and Market Share by Country (2015-2020)
8.2 Brazil Huntington Disease Protein Sales and Growth Rate (2015-2020)
8.3 Argentina Huntington Disease Protein Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Huntington Disease Protein Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Huntington Disease Protein Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Huntington Disease Protein Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Huntington Disease Protein Sales and Growth Rate (2015-2020)
9.3 Turkey Huntington Disease Protein Sales and Growth Rate (2015-2020)
9.4 Egypt Huntington Disease Protein Sales and Growth Rate (2015-2020)
9.5 South Africa Huntington Disease Protein Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Huntington Disease Protein Sales and Market Share by Type (2015-2020)
10.2 Global Huntington Disease Protein Revenue and Market Share by Type (2015-2020)
10.3 Global Huntington Disease Protein Price by Type (2015-2020)
11 Global Huntington Disease Protein Market Segment by Application
11.1 Global Huntington Disease Protein Sales Market Share by Application (2015-2020)
11.2 Global Huntington Disease Protein Revenue Market Share by Application (2015-2020)
11.3 Global Huntington Disease Protein Price by Application (2015-2020)
12 Market Forecast
12.1 Global Huntington Disease Protein Sales, Revenue and Growth Rate (2021-2025)
12.2 Huntington Disease Protein Market Forecast by Regions (2021-2025)
12.2.1 North America Huntington Disease Protein Market Forecast (2021-2025)
12.2.2 Europe Huntington Disease Protein Market Forecast (2021-2025)
12.2.3 Asia-Pacific Huntington Disease Protein Market Forecast (2021-2025)
12.2.4 South America Huntington Disease Protein Market Forecast (2021-2025)
12.2.5 Middle East & Africa Huntington Disease Protein Market Forecast (2021-2025)
12.3 Huntington Disease Protein Market Forecast by Type (2021-2025)
12.3.1 Global Huntington Disease Protein Sales Forecast by Type (2021-2025)
12.3.2 Global Huntington Disease Protein Market Share Forecast by Type (2021-2025)
12.4 Huntington Disease Protein Market Forecast by Application (2021-2025)
12.4.1 Global Huntington Disease Protein Sales Forecast by Application (2021-2025)
12.4.2 Global Huntington Disease Protein Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Huntington Disease Protein Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Huntington Disease Protein by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Huntington Disease Protein Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AFFiRiS AG Basic Information, Manufacturing Base and Competitors
Table 8. AFFiRiS AG Huntington Disease Protein Major Business
Table 9. AFFiRiS AG Huntington Disease Protein Total Revenue (USD Million) (2018-2019)
Table 10. AFFiRiS AG SWOT Analysis
Table 11. AFFiRiS AG Huntington Disease Protein Product and Services
Table 12. AFFiRiS AG Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Voyager Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Voyager Therapeutics, Inc. Huntington Disease Protein Major Business
Table 15. Voyager Therapeutics, Inc. Huntington Disease Protein Total Revenue (USD Million) (2018-2019)
Table 16. Voyager Therapeutics, Inc. SWOT Analysis
Table 17. Voyager Therapeutics, Inc. Huntington Disease Protein Product and Services
Table 18. Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. nLife Therapeutics, S.L. Basic Information, Manufacturing Base and Competitors
Table 20. nLife Therapeutics, S.L. Huntington Disease Protein Major Business
Table 21. nLife Therapeutics, S.L. Huntington Disease Protein Total Revenue (USD Million) (2018-2019)
Table 22. nLife Therapeutics, S.L. SWOT Analysis
Table 23. nLife Therapeutics, S.L. Huntington Disease Protein Product and Services
Table 24. nLife Therapeutics, S.L. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 26. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Major Business
Table 27. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Total Revenue (USD Million) (2018-2019)
Table 28. Ionis Pharmaceuticals, Inc. SWOT Analysis
Table 29. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product and Services
Table 30. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. UniQure N.V. Basic Information, Manufacturing Base and Competitors
Table 32. UniQure N.V. Huntington Disease Protein Major Business
Table 33. UniQure N.V. Huntington Disease Protein Total Revenue (USD Million) (2018-2019)
Table 34. UniQure N.V. SWOT Analysis
Table 35. UniQure N.V. Huntington Disease Protein Product and Services
Table 36. UniQure N.V. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Neurimmune Holding AG Basic Information, Manufacturing Base and Competitors
Table 38. Neurimmune Holding AG Huntington Disease Protein Major Business
Table 39. Neurimmune Holding AG Huntington Disease Protein Total Revenue (USD Million) (2018-2019)
Table 40. Neurimmune Holding AG SWOT Analysis
Table 41. Neurimmune Holding AG Huntington Disease Protein Product and Services
Table 42. Neurimmune Holding AG Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. WAVE Life Sciences Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. WAVE Life Sciences Ltd. Huntington Disease Protein Major Business
Table 45. WAVE Life Sciences Ltd. Huntington Disease Protein Total Revenue (USD Million) (2018-2019)
Table 46. WAVE Life Sciences Ltd. SWOT Analysis
Table 47. WAVE Life Sciences Ltd. Huntington Disease Protein Product and Services
Table 48. WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Sangamo BioSciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 50. Sangamo BioSciences, Inc. Huntington Disease Protein Major Business
Table 51. Sangamo BioSciences, Inc. Huntington Disease Protein Total Revenue (USD Million) (2018-2019)
Table 52. Sangamo BioSciences, Inc. SWOT Analysis
Table 53. Sangamo BioSciences, Inc. Huntington Disease Protein Product and Services
Table 54. Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. reMYND NV Basic Information, Manufacturing Base and Competitors
Table 56. reMYND NV Huntington Disease Protein Major Business
Table 57. reMYND NV Huntington Disease Protein Total Revenue (USD Million) (2018-2019)
Table 58. reMYND NV SWOT Analysis
Table 59. reMYND NV Huntington Disease Protein Product and Services
Table 60. reMYND NV Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Vybion, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Vybion, Inc. Huntington Disease Protein Major Business
Table 63. Vybion, Inc. Huntington Disease Protein Total Revenue (USD Million) (2018-2019)
Table 64. Vybion, Inc. SWOT Analysis
Table 65. Vybion, Inc. Huntington Disease Protein Product and Services
Table 66. Vybion, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Huntington Disease Protein Sales by Manufacturer (2018-2019) (K Pcs)
Table 68. Global Huntington Disease Protein Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Huntington Disease Protein Sales by Regions (2015-2020) (K Pcs)
Table 70. Global Huntington Disease Protein Sales Market Share by Regions (2015-2020)
Table 71. Global Huntington Disease Protein Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Huntington Disease Protein Sales by Countries (2015-2020) (K Pcs)
Table 73. North America Huntington Disease Protein Sales Market Share by Countries (2015-2020)
Table 74. North America Huntington Disease Protein Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Huntington Disease Protein Revenue Market Share by Countries (2015-2020)
Table 76. Europe Huntington Disease Protein Sales by Countries (2015-2020) (K Pcs)
Table 77. Europe Huntington Disease Protein Sales Market Share by Countries (2015-2020)
Table 78. Europe Huntington Disease Protein Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Huntington Disease Protein Sales by Regions (2015-2020) (K Pcs)
Table 80. Asia-Pacific Huntington Disease Protein Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Huntington Disease Protein Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Huntington Disease Protein Sales by Countries (2015-2020) (K Pcs)
Table 83. South America Huntington Disease Protein Sales Market Share by Countries (2015-2020)
Table 84. South America Huntington Disease Protein Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Huntington Disease Protein Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Huntington Disease Protein Sales by Countries (2015-2020) (K Pcs)
Table 87. Middle East & Africa Huntington Disease Protein Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Huntington Disease Protein Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Huntington Disease Protein Revenue Market Share by Countries (2015-2020)
Table 90. Global Huntington Disease Protein Sales by Type (2015-2020) (K Pcs)
Table 91. Global Huntington Disease Protein Sales Share by Type (2015-2020)
Table 92. Global Huntington Disease Protein Revenue by Type (2015-2020) (USD Million)
Table 93. Global Huntington Disease Protein Revenue Share by Type (2015-2020)
Table 94. Global Huntington Disease Protein Sales by Application (2015-2020) (K Pcs)
Table 95. Global Huntington Disease Protein Sales Share by Application (2015-2020)
Table 96. Global Huntington Disease Protein Sales Forecast by Regions (2021-2025) (K Pcs)
Table 97. Global Huntington Disease Protein Market Share Forecast by Regions (2021-2025)
Table 98. Global Huntington Disease Protein Sales Forecast by Type (2021-2025) (K Pcs)
Table 99. Global Huntington Disease Protein Market Share Forecast by Type (2021-2025)
Table 100. Global Huntington Disease Protein Sales Forecast by Application (2021-2025)
Table 101. Global Huntington Disease Protein Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Huntington Disease Protein Picture
Figure 2. Global Sales Market Share of Huntington Disease Protein by Type in 2019
Figure 3. NI-302 Picture
Figure 4. NLF-HD Picture
Figure 5. P-301905 Picture
Figure 6. IONIS-HTTRx Picture
Figure 7. Others Picture
Figure 8. Huntington Disease Protein Sales Market Share by Application in 2018
Figure 9. Alzheimer's Disease Picture
Figure 10. Kennedy's Disease Picture
Figure 11. Spinocerebellar Ataxia Picture
Figure 12. Others Picture
Figure 13. Global Huntington Disease Protein Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Huntington Disease Protein Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Huntington Disease Protein Sales Market Share by Manufacturer in 2019
Figure 34. Global Huntington Disease Protein Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Huntington Disease Protein Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Huntington Disease Protein Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Huntington Disease Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Huntington Disease Protein Revenue Market Share by Regions (2015-2020)
Figure 41. Global Huntington Disease Protein Revenue Market Share by Regions in 2018
Figure 42. North America Huntington Disease Protein Sales and Growth Rate (2015-2020)
Figure 43. Europe Huntington Disease Protein Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Huntington Disease Protein Sales and Growth Rate (2015-2020)
Figure 45. South America Huntington Disease Protein Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Huntington Disease Protein Sales and Growth Rate (2015-2020)
Figure 47. North America Huntington Disease Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Huntington Disease Protein Sales Market Share by Countries (2015-2020)
Figure 49. North America Huntington Disease Protein Sales Market Share by Countries in 2018
Figure 50. North America Huntington Disease Protein Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Huntington Disease Protein Revenue Market Share by Countries in 2018
Figure 52. United States Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Huntington Disease Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Huntington Disease Protein Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Huntington Disease Protein Revenue Market Share by Countries in 2019
Figure 58. Germany Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Huntington Disease Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Huntington Disease Protein Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Huntington Disease Protein Revenue Market Share by Regions 2019
Figure 66. China Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Huntington Disease Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Huntington Disease Protein Sales Market Share by Countries in 2019
Figure 73. South America Huntington Disease Protein Revenue Market Share by Countries in 2019
Figure 74. Brazil Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Huntington Disease Protein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Huntington Disease Protein Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Huntington Disease Protein Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Huntington Disease Protein Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Huntington Disease Protein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Huntington Disease Protein Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Huntington Disease Protein Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Huntington Disease Protein Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Huntington Disease Protein Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Huntington Disease Protein Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Huntington Disease Protein Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Huntington Disease Protein Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
アルツハイマー病治療薬の世界市場 2020年 Market Overview The Alzheimer's Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- アルツハイマー病治療の世界市場 2020年 Market Overview The global Alzheimer's Disease Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alzheimer's Di…
- 感染症治療薬の世界市場 2020年 Market Overview The global Infectious Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Infectious Disease D…
- カナバン病治療薬の世界市場 2020年 Market Overview The global Canavan Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canavan Disease …
- メニエール病治療薬の世界市場 2020年 Market Overview The global Meniere Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere Disease Drugs m…